Document is current
Any future updates will be listed below
-
Authors
Hu, Lianying
Cheng, Zhen
Wu, Lunan
Luo, Liangliang
Pan, Ping
Li, Shujin
Jia, Qiyu
Yang, Ning
Xu, Bin
-
Funding
Funding for this research was provided by:
key natural and science projects of Bengbu Medical College (No. 2020byzd308)
- License Information
-
More Information
Article History
Received: 20 November 2022
Accepted: 24 March 2023
First Online: 19 April 2023
Declarations
:
: The authors declare no conflicts of interest.
: The current study was performed with the approval of the Ethics Committee of the Second People’s Hospital of Hefei, Hefei Hospital Affiliated to Anhui Medical University and performed in strict accordance with the <i>Declaration of Helsinki</i> (Protocol No.: HF2H-CE-2022–0317). Signed informed consents were obtained from all participants prior to enrollment and in strict accordance with the recommendations of the Guide for the Care and Use of Laboratory Animals (Protocol No.: HF2H-AE-2022–0317). Histone methyltransferase SETDB1 promotes osteogenic differentiation in osteoporosis by activating OTX2-mediated BMP-Smad and Wnt/β-catenin pathways.
